InvestorsObserver
×
News Home

Is Annovis Bio Inc (ANVS) a Leader in the Biotechnology Industry?

Thursday, December 28, 2023 02:15 PM | InvestorsObserver Analysts

Mentioned in this article

Is Annovis Bio Inc (ANVS) a Leader in the Biotechnology Industry?

A rating of 98 puts Annovis Bio Inc (ANVS) near the top of the Biotechnology industry according to InvestorsObserver. Annovis Bio Inc's score of 98 means it scores higher than 98% of stocks in the industry. Annovis Bio Inc also received an overall rating of 84, putting it above 84% of all stocks. Biotechnology is ranked 41 out of the 148 industries.

Overall Score - 84
ANVS has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on ANVS!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 84 means the stock is more attractive than 84 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Annovis Bio Inc Stock Today?

Annovis Bio Inc (ANVS) stock is trading at $19.68 as of 1:51 PM on Thursday, Dec 28, an increase of $0.06, or 0.31% from the previous closing price of $19.62. Volume today is 371,689 compared to average volume of 322,536. The stock has traded between $19.42 and $21.50 so far today. Click Here to get the full Stock Report for Annovis Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App